Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

For the eighth year running, the University of Oxford’s Medical School is ranked highest of all UK medical school in terms of student satisfaction.

Image courtesy of Shutterstock

The result comes from the National Student Survey, an annual online survey of all final year students in all degree courses in UK Higher Education Institutions. In the survey, 98% of Oxford medical students answered ‘agree’ or ‘definitely agree’ to the question “Overall, I am satisfied with the quality of the course.” Additionally, 87% of these students answered this question with ‘definitely agree’: by far the highest proportion in any UK medical school.

Professor David Paterson, Deputy Head & Vice Dean Medical Sciences Division (Education) commented: 'This is a very pleasing outcome and continues to demonstrate the outstanding commitment of our colleagues in providing a first class student experience in a research intensive environment.'

Dr Tim Lancaster, Director of Clinical Studies said, “This year, for the first time, the General Medical Council published pass rates for  postgraduate examinations in all medical specialties by medical school of origin. This analysis showed that Oxford graduates achieved higher levels of success than graduates of all other  UK medical schools. We are very pleased that Oxford has such positive outcomes for both these quality indicators, student satisfaction and graduate achievement.’

Links:

Similar stories

Com-COV vaccine study to research third dose booster options for 12-to-15-year-olds

Researchers running the University of Oxford-led Com-COV programme have launched a further study of COVID-19 vaccination schedules in young people aged 12 to 15 – with a focus on assessing different options for a third dose booster vaccination.

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.